JAXtaposition - Cancer

SPEAKERS BIOGRAPHIES

Mark Adams, Ph.D., Deputy Director, Professor and Director of Microbial Genomic Services at JAX GM

Dr. Mark Adams is Deputy Director, Professor and Director of Microbial Genomic Services at The Jackson Laboratory for Genomic Medicine in Farmington, CT. His group develops and applies approaches to microbial profiling in human studies and develops mouse models for demonstrating the roles of microbes in health and disease states.

Dr. Adams was a co-founder of The Institute for Genomic Research and Celera Genomics, where he led the DNA sequencing and genome annotation groups. From 2003-2011, Dr. Adams was Associate Professor of Genetics at Case Western Reserve University. From 2011-2016, he was the Scientific Director and Professor at the J. Craig Venter Institute. There he directed programs that characterized genomic changes in the evolution of antibiotic resistance in hospital-acquired infections.

Dr. Adams has a BA in Chemistry from Warren Wilson College and a PhD in Biological Chemistry from the University of Michigan.

Francesca Menghi, Ph.D., Associate Research Scientist

Francesca Menghi obtained her B.Sc. and M.Res. from the University of Milan, Italy, where she identified genetic alterations that affect brain cancer patients’ prognosis. She earned her Ph.D. in cancer biology at University College London, where she studied transcriptional changes in childhood brain cancer. In 2010, she joined Dr. Ed Liu’s lab at the Genome Institute of Singapore as a postdoctoral fellow, studying the genome-wide patterns of alterations that are implicated in the origin and evolution of human cancer. In 2013, she joined The Jackson Laboratory for Genomic Medicine in Farmington, Conn., as an associate research scientist.